ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,865Medicare Part D Prescriptions Filled, Including Refills

Rank: 262 out of 939

$721K Total Retail Price of All Prescriptions

Rank: 120 out of 939

339 Patients Receiving at Least One Drug in Part D
52%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

27% of this provider’s 339 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

45% of this provider’s 339 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

4% of this provider’s 4,583 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$73 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
HYDROCODONE-ACETAMINOPHEN 1,035 411 S3 1 1
CARISOPRODOL 268 65 R 2 51
OMEPRAZOLE 225 133 3 5
AMLODIPINE BESYLATE 216 139 4 6
OXYCODONE HCL 207 71 S2 5 67
LISINOPRIL 203 105 6 3
ZOLPIDEM TARTRATE 199 97 7 20
METFORMIN HCL 185 124 8 8
CRESTOR 177 62 9 34
OXYCODONE HCL-ACETAMINOPHEN 168 65 S2 10 107
LEVOTHYROXINE SODIUM 160 98 11 4
METOPROLOL TARTRATE 149 68 12 10
NEXIUM 143 40 13 18
CYCLOBENZAPRINE HCL 134 34 R 14 36
FUROSEMIDE 126 68 15 7
CYMBALTA 126 38 15 44
GABAPENTIN 124 46 17 11
TIZANIDINE HCL 114 34 18 81
CLONIDINE HCL 114 68 18 39
CITALOPRAM HBR 113 30 20 15
GLIMEPIRIDE 112 63 21 37
PRAVASTATIN SODIUM 109 68 22 13
LYRICA 107 15 23 63
TRAZODONE HCL 102 39 24 26
MIRTAZAPINE 96 55 25 56
MORPHINE SULFATE 93 35 S2 26 186
PROMETHAZINE HCL 91 26 R 27 68
MELOXICAM 91 55 27 14
POTASSIUM CHLORIDE 87 53 29 9
ENDOCET 79 39 S2 30 148
DIGOXIN 78 63 31 45
LISINOPRIL-HYDROCHLOROTHIAZIDE 78 28 31 23
EXFORGE 78 54 31 176
AMOXICILLIN 78 38 31 92
CLOPIDOGREL 73 37 35 28
PLAVIX 73 44 35 48
SULFAMETHOXAZOLE-TRIMETHOPRIM 73 38 35 64
GEMFIBROZIL 69 47 38 100
PROAIR HFA 65 57 39 41
ESCITALOPRAM OXALATE 65 23 39 61
FENTANYL 65 21 S2 39 104
BENAZEPRIL HCL 62 40 42 87
CELEBREX 60 45 43 106
ROPINIROLE HCL 58 21 44 78
SPIRIVA 57 45 45 73
BACLOFEN 54 0 46 157
DONEPEZIL HCL 53 53 47 30
SERTRALINE HCL 53 0 47 24
WARFARIN SODIUM 50 39 49 17
ADVAIR DISKUS 50 40 49 60
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.